Cardiovascular Risk Assessment: A Systematic Review of Guidelines

Mohammed Y Khanji1, Vinícius V S Bicalho1, Claudia N van Waardhuizen1

  • 1From Queen Mary University of London, London, United Kingdom; Federal University of Juiz de Fora School of Medicine, Juiz de Fora, Minas Gerais, Brazil; Erasmus Medical Center, Rotterdam, the Netherlands; and Icahn School of Medicine at Mount Sinai, New York, New York.

Annals of Internal Medicine
|September 13, 2016
PubMed

Insights

Current cardiovascular disease screening guidelines lack consensus on optimal strategies and treatment thresholds. This review highlights discrepancies to aid clinicians in primary prevention decision-making for healthy adults.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Health Policy

Background:

  • Numerous guidelines exist for cardiovascular disease (CVD) primary prevention screening and risk assessment in healthy individuals.
  • The need for clear, consistent guidance is paramount for effective clinical decision-making.

Purpose of the Study:

  • To systematically review current primary prevention guidelines for adult cardiovascular risk assessment.
  • To identify and highlight similarities and differences among these guidelines to support clinicians.

Main Methods:

  • A systematic literature search was conducted in MEDLINE and CINAHL from May 2009 to June 2016.
  • Guidelines from Western countries recommending cardiovascular risk assessment for healthy adults were identified and screened.
  • The rigor of guideline development was assessed using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument.

Main Results:

  • Of 21 identified guidelines, 17 demonstrated considerable rigor in development.
  • Recommendations covered total CVD risk, dysglycemia, dyslipidemia, and hypertension assessment.
  • While most guidelines advocate for screening using prediction models, no consensus exists on screening strategies, target populations, tests, or treatment thresholds.

Conclusions:

  • Significant discrepancies persist among cardiovascular screening guidelines.
  • There is a lack of consensus on optimal screening strategies and treatment thresholds for primary CVD prevention.
  • Further harmonization of guidelines is needed to improve clinical practice and patient outcomes.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.0K
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
936
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
794
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K